全文获取类型
收费全文 | 9282篇 |
免费 | 482篇 |
国内免费 | 22篇 |
专业分类
耳鼻咽喉 | 128篇 |
儿科学 | 615篇 |
妇产科学 | 138篇 |
基础医学 | 818篇 |
口腔科学 | 178篇 |
临床医学 | 751篇 |
内科学 | 2523篇 |
皮肤病学 | 235篇 |
神经病学 | 503篇 |
特种医学 | 239篇 |
外科学 | 1271篇 |
综合类 | 205篇 |
预防医学 | 405篇 |
眼科学 | 349篇 |
药学 | 556篇 |
中国医学 | 16篇 |
肿瘤学 | 856篇 |
出版年
2023年 | 45篇 |
2022年 | 100篇 |
2021年 | 288篇 |
2020年 | 138篇 |
2019年 | 187篇 |
2018年 | 274篇 |
2017年 | 146篇 |
2016年 | 163篇 |
2015年 | 191篇 |
2014年 | 284篇 |
2013年 | 350篇 |
2012年 | 534篇 |
2011年 | 555篇 |
2010年 | 313篇 |
2009年 | 222篇 |
2008年 | 426篇 |
2007年 | 488篇 |
2006年 | 458篇 |
2005年 | 407篇 |
2004年 | 400篇 |
2003年 | 335篇 |
2002年 | 331篇 |
2001年 | 267篇 |
2000年 | 239篇 |
1999年 | 217篇 |
1998年 | 101篇 |
1997年 | 54篇 |
1996年 | 47篇 |
1995年 | 63篇 |
1993年 | 43篇 |
1992年 | 168篇 |
1991年 | 172篇 |
1990年 | 169篇 |
1989年 | 151篇 |
1988年 | 141篇 |
1987年 | 129篇 |
1986年 | 112篇 |
1985年 | 106篇 |
1984年 | 105篇 |
1983年 | 74篇 |
1982年 | 51篇 |
1981年 | 42篇 |
1980年 | 39篇 |
1979年 | 84篇 |
1978年 | 40篇 |
1977年 | 62篇 |
1974年 | 49篇 |
1972年 | 48篇 |
1970年 | 43篇 |
1969年 | 38篇 |
排序方式: 共有9786条查询结果,搜索用时 15 毫秒
131.
A strong foundation in microsurgical techniques is imperative for urologists and clinical andrologists specializing in male infertility. Laboratory-based microsurgical training enhances surgical skills, improves surgeon confidence, and reduces stress and operating time, thereby benefiting both the patient and the surgeon. The laboratory environment additionally allows for the development of novel and innovative techniques. This review provides guidelines for setting up a microsurgical laboratory to develop and enhance microsurgical skills using synthetic and animal models. 相似文献
132.
133.
134.
Natasha Purai Arora Mouhammed Joumaa Howard Rosman Raj Mehta 《The American journal of the medical sciences》2017,353(6):597-602
Left main coronary artery (LMCA) thrombosis with acute myocardial infarction is a rare condition with very high mortality. The low incidence of this condition and exclusion of patients with LMCA thrombosis from clinical trials prevent the development of optimal management strategy in these patients. Therefore, there are no clear-cut guidelines describing an evidence-based approach for this condition. We describe a patient with LMCA thrombosis presenting with acute myocardial infarction, who was found to have hypercoagulable state related to homocysteinemia on further work-up. This case highlights the challenges faced during the management of this rare condition due to lack of clear-cut guidelines describing an evidence-based approach. 相似文献
135.
136.
137.
Carrie Heincelman Seth Brown Eric England Kaushal Mehta Robert D. Wissman 《Skeletal radiology》2014,43(9):1297-1299
Rib stress injuries are uncommonly reported but have been documented among athletes, most notably rowers. There have only been two prior case reports of rib stress injuries in swimmers, both of which were young females. Magnetic resonance (MR) imaging was either not obtained or the imaging characteristics were incompletely described. We present a case of an isolated third rib stress injury in a collegiate male swimmer diagnosed via MR imaging. We briefly discuss the possible etiologies for rib stress injuries, their MR appearance, as well as their treatment. 相似文献
138.
139.
140.
Dae Won Kim Elaine Tan Jun-Min Zhou Michael J. Schell Maria Martinez James Yu Estrella Carballido Rutika Mehta Jonathan Strosberg Iman Imanirad Richard D. Kim 《British journal of cancer》2021,124(11):1803
Background MMR proficient (pMMR) colorectal cancer (CRC) is usually unresponsive to immunotherapy. Recent data suggest that ibrutinib may enhance the anti-tumour activity of anti-PD-1 immunotherapy. In this study, we evaluated the safety and efficacy of ibrutinib plus pembrolizumab in refractory metastatic CRC.Methods This was a phase 1/2 study in patients with refractory metastatic pMMR CRC. The primary endpoints for phases 1 and 2 were maximum tolerated dose (MTD) and disease control rate, respectively. The secondary endpoints were safety, progression-free survival (PFS) and overall survival (OS).Results A total of 40 patients were enrolled. No dose-limiting toxicity was observed, and MTD was not identified. The highest tested dose of ibrutinib, 560 mg once daily, was combined with a fixed dose of pembrolizumab 200 mg every 3 weeks for the phase 2 portion. The most common grade 3/4 treatment-related adverse events were anaemia (21%), fatigue (8%) and elevated alkaline phosphatase (8%). Among 31 evaluable patients, 8 (26%) achieved stable disease, and no objective response was observed. The median PFS and OS were 1.4 and 6.6 months, respectively.Conclusion Ibrutinib 560 mg daily plus pembrolizumab 200 mg every 3 weeks appears to be well tolerated with limited anti-cancer activity in metastatic CRC.ClinicalTrials.gov identifier .Subject terms: NCT03332498Cancer immunotherapy, Colorectal cancer 相似文献